Dorsch Marion

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$6.12M

Insider Activity of Dorsch Marion

The largest sale of all time was on 2017-11-22 and amounted to 18332 shares of Blueprint Medicines Corporation for $981,770.

Biography of Dorsch Marion

No biography is available at this moment.

2021-02-22SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
7,578
0.0133%
$100.00$757,800-2.82%
2020-12-14SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
4,600
0.0083%
$119.00$547,400-17.42%
2020-10-06SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
4,600
0.0084%
$99.00$455,400+0.48%
2020-09-23SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
4,600
0.0083%
$89.00$409,400+7.86%
2020-06-19SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
9,200
0.0125%
$58.05$534,106+21.85%
2020-03-23SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
2,428
0.0047%
$52.49$127,452+63.07%
2020-03-09SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
1,072
0.0019%
$51.99$55,733+44.05%
2019-12-19SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
9,200
0.0143%
$58.05$534,106-4.26%
2019-06-17SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
9,200
0.0136%
$68.06$626,106-21.99%
2019-03-04SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
4,600
0.0104%
$84.66$389,446-7.57%
2018-09-17SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
4,600
0.0107%
$70.31$323,446+11.85%
2018-03-15SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
4,600
0.007%
$68.59$315,514-31.4%
2017-11-22SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
18,332
0.0369%
$53.55$981,770+6.31%
2017-11-21SaleBlueprint Medicines Corporation
BPMC
Chief Scientific Officer
1,000
0.0026%
$64.44$64,440+13.63%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.